ArticleFrontiers in public health2026
Associations between twelve composite inflammatory indices and sarcopenia in a health examination population: a cross-sectional study.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcopenia is strongly linked to chronic inflammation, yet most studies have focused on individual inflammatory markers. Moreover, associations between inflammatory status and sarcopenia have not been systematically compared in health examination populations. This study explored the relationships between composite inflammatory indices and sarcopenia in individuals undergoing routine health examinations. Methods: This retrospective cross-sectional study included 2617 participants from a health examination cohort. Composite inflammatory indices were derived from peripheral blood cell counts and standard biochemical parameters. Independent associations between each index and sarcopenia were examined using multivariable logistic regression. Subgroup analyses by sex and age were conducted, restricted cubic spline models assessed potential non-linear relationships, and receiver operating characteristic curves were used to compare discriminative performance. Results: Among 2,617 participants, sarcopenia prevalence was 5.5%. After adjustment for confounders, higher inflammatory status was associated with increased sarcopenia risk. The C-reactive protein-to-lymphocyte ratio (CLR) showed the strongest association (Q4 vs. Q1: OR = 4.31, 95% CI 2.35-7.90). Higher levels of the C-reactive protein-to-albumin ratio (CAR), systemic immune-inflammation index (SII), and platelet-to-lymphocyte ratio (PLR) were also significantly associated with higher sarcopenia risk. Associations were consistent across sex and age subgroups (all interaction Conclusion: Several composite inflammatory indices derived from routine laboratory data are associated with sarcopenia risk in health examination populations and may provide additional information for assessing inflammation-related sarcopenia risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.